Get the Stockscreener App
30.03
0.96%
-0.29
Cg Oncology Inc Stock (CGON) Latest News
Market Watch Highlights: Cg Oncology Inc (CGON) Ends on an Upturn Note at 30.32 - The Dwinnex
CGON Stock Sees Surge of Approximately 0.10% in Last Five Days - Knox Daily
CG Oncology, Inc. (NASDAQ:CGON) is a favorite amongst institutional investors who own 62% - Yahoo Canada Finance
China Universal Asset Management Co. Ltd. Makes New Investment in CG Oncology, Inc. (NASDAQ:CGON) - MarketBeat
Reviewing Cardiol Therapeutics (NASDAQ:CRDL) and CG Oncology (NASDAQ:CGON) - Defense World
Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
CG Oncology, Inc. (NASDAQ:CGON) Stock Holdings Boosted by JPMorgan Chase & Co. - Defense World
CG Oncology, Inc. (NASDAQ:CGON) Shares Purchased by JPMorgan Chase & Co. - MarketBeat
Analysts Offer Predictions for CG Oncology FY2025 Earnings - Defense World
CG Oncology, Inc. (NASDAQ:CGON) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
CG Oncology, Inc. (NASDAQ:CGON) Receives Average Recommendation of “Buy” from Analysts - Defense World
Cantor Fitzgerald Comments on CG Oncology FY2025 Earnings - MarketBeat
Oncolytic Virus Cancer Therapy Pipeline 2024: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight | CG Oncology, Targovax, Transgene, Istari Oncology, Targovax, Oncolytics Biotech - The Globe and Mail
Oncolytic Virus Cancer Therapy Pipeline 2024: Therapies, MOA - openPR
This CG Oncology Insider Reduced Their Stake By 16% - Simply Wall St
Does CG Oncology, Inc. (CGON) Have the Potential to Rally 123.34% as Wall Street Analysts Expect? - MSN
Cg Oncology Inc (CGON) Volatility Hits 4.53%: What Good Investors Need To Be Aware Of - Stocks Register
Cg oncology director Leonard Post sells shares worth $29,660 By Investing.com - Investing.com Australia
Cg oncology director Leonard Post sells shares worth $29,660 - Investing.com India
CG Oncology, Inc. (NASDAQ:CGON) Director Leonard E. Post Sells 1,000 Shares - MarketBeat
CG Oncology (NASDAQ:CGON) Earns “Buy” Rating from HC Wainwright - Defense World
CG Oncology amends executive compensation agreements By Investing.com - Investing.com Canada
CG Oncology amends executive compensation agreements - Investing.com India
A First Take On CG Oncology (NASDAQ:CGON) - Seeking Alpha
CG Oncology's (CGON) "Buy" Rating Reiterated at HC Wainwright - MarketBeat
Pfizer study impact on CG Oncology to be minimal, says H.C. Wainwright - TipRanks
CG Oncology (NASDAQ:CGON) Research Coverage Started at TD Cowen - Defense World
TD Cowen Initiates Coverage of CG Oncology (CGON) with Buy Recommendation - MSN
CG Oncology (NASDAQ:CGON) Stock Price Up 7.5%Time to Buy? - MarketBeat
TD Cowen initiates CG Oncology stock with Buy rating By Investing.com - Investing.com Canada
CG Oncology (NASDAQ:CGON) Now Covered by TD Cowen - MarketBeat
TD Cowen initiates CG Oncology stock with Buy rating - Investing.com
CG Oncology, Inc. (NASDAQ:CGON) Short Interest Down 5.3% in December - MarketBeat
CG Oncology (NASDAQ:CGON) Stock Price Down 6.9%Time to Sell? - MarketBeat
CG Oncology, Inc. (NASDAQ:CGON) Receives Consensus Recommendation of "Buy" from Brokerages - MarketBeat
CG Oncology, Inc. (NASDAQ:CGON) Given Consensus Rating of “Buy” by Brokerages - Defense World
Head-To-Head Analysis: Atyr PHARMA (NASDAQ:ATYR) versus CG Oncology (NASDAQ:CGON) - Defense World
CG Oncology : Reports Third Quarter 2024 Financial Results and Provides Business Updates Form 8 K - Marketscreener.com
CG Oncology (NASDAQ:CGON) Shares Up 2.5%Still a Buy? - MarketBeat
Comparing Tarsus Pharmaceuticals (NASDAQ:TARS) and CG Oncology (NASDAQ:CGON) - Defense World
Geode Capital Management LLC Has $40.70 Million Holdings in CG Oncology, Inc. (NASDAQ:CGON) - Defense World
Geode Capital Management LLC Increases Stake in CG Oncology, Inc. (NASDAQ:CGON) - MarketBeat
Barclays PLC Increases Stock Holdings in CG Oncology, Inc. (NASDAQ:CGON) - Defense World
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 2,503 Shares of CG Oncology, Inc. (NASDAQ:CGON) - Defense World
CG Oncology (NASDAQ:CGON) Shares Down 4.3%Time to Sell? - MarketBeat
CG Oncology Enters Oversold Territory (CGON) - Nasdaq
State Street Corp Raises Stake in CG Oncology, Inc. (NASDAQ:CGON) - Defense World
State Street Corp Acquires 717,722 Shares of CG Oncology, Inc. (NASDAQ:CGON) - MarketBeat
Cg oncology director Leonard Post sells $28,840 in stock By Investing.com - Investing.com Australia
0.82%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):